title: Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Other studies have not shown increased mortality.
authors.forename: O
authors.initials: O
authors.lastname: Mäki-Ikola
authors.forename: O
authors.initials: O
authors.lastname: Kilkku
authors.forename: E
authors.initials: E
authors.lastname: Heinonen
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects*; D018849:Controlled Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D015201:Meta-Analysis as Topic; D010300:Parkinson Disease / Q000188:drug therapy / Q000401:mortality*; D012642:Selegiline / Q000009:adverse effects*
chemical_list: D000978:Antiparkinson Agents; D012642:Selegiline; D007980:Levodopa